
News|Articles|December 8, 2014
Treating HIV-Associated Lymphoma
Author(s)Joseph Alvarnas, MD
Joseph Alvarnas, MD, Director of Medical Quality, associate clinical professor, City of Hope, discusses the treatment of HIV-associated lymphoma.
Advertisement
Clinical Pearls
Joseph Alvarnas, MD, Director of Medical Quality, associate clinical professor, City of Hope, discusses the treatment of HIV-associated lymphoma.
- The most appropriate way to treat patients with HIV and lymphoma has been a quandary for years.
- This study looked at autologous hematopoietic stem cell transplantation for the treatment of patients with chemotherapy-sensitive, relapsed/refractory HIV-associated lymphoma.
- Estimated probability of one-year OS was 86.6%.
<<<
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
2
The Targeted Pulse: New Standards in Myeloma, Melanoma, and More
3
Onvansertib Triplet Shows Dose-Dependent Frontline Benefit in RAS-Mutant Metastatic CRC
4
Pembrolizumab/Lenvatinib Show Efficacy, Safety in Clear Cell Gyn Cancers
5



















